Hengrui Medicine (01276.HK) repurchased 10,694,400 shares as of February 28

NightAirdropper · 2026-03-04T17:40:06+00:00

Hengrui Medicine repurchased 906,000 shares through centralized bidding in February 2026, accounting for 0.014% of the total share capital. The total repurchase amount was 51.48 million yuan. By the end of February, the company had cumulatively repurchased 10,694,400 shares, with a total expenditure of 697.7694 million yuan.

NightAirdropper

2026-03-04 17:40:06

Abstract generation in progress

Gelonghui March 2 — Hengrui Medicine (01276.HK) announced that in February 2026, the company repurchased 906,000 shares through the Shanghai Stock Exchange trading system via centralized bidding, representing 0.014% of the company’s total share capital. The highest purchase price was RMB 57.46 per share, and the lowest was RMB 56.25 per share. The total amount paid was RMB 51.4807 million (excluding transaction fees).

As of February 28, 2026, the company’s total share repurchase through the Shanghai Stock Exchange trading system via centralized bidding reached 10,694,400 shares, accounting for 0.16% of the total share capital. The highest purchase price was RMB 70.00 per share, and the lowest was RMB 56.10 per share. The total amount paid was RMB 697.7694 million (excluding transaction fees).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.